Literature DB >> 16670093

Diminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha)-deficient mice.

Shawn C Burgess1, Teresa C Leone, Adam R Wende, Michelle A Croce, Zhouji Chen, A Dean Sherry, Craig R Malloy, Brian N Finck.   

Abstract

The peroxisome proliferator-activated receptor gamma (PPARgamma) coactivator 1alpha (PGC-1alpha) is a highly inducible transcriptional coactivator implicated in the coordinate regulation of genes encoding enzymes involved in hepatic fatty acid oxidation, oxidative phosphorylation, and gluconeogenesis. The present study sought to assess the effects of chronic PGC-1alpha deficiency on metabolic flux through the hepatic gluconeogenic, fatty acid oxidation, and tricarboxylic acid cycle pathways. To this end, hepatic metabolism was assessed in wild-type (WT) and PGC-1alpha(-/-) mice using isotopomer-based NMR with complementary gene expression analyses. Hepatic glucose production was diminished in PGC-1alpha(-/-) livers coincident with reduced gluconeogenic flux from phosphoenolpyruvate. Surprisingly, the expression of PGC-1alpha target genes involved in gluconeogenesis was unaltered in PGC-1alpha(-/-) compared with WT mice under fed and fasted conditions. Flux through tricarboxylic acid cycle and mitochondrial fatty acid beta-oxidation pathways was also diminished in PGC-1alpha(-/-) livers. The expression of multiple genes encoding tricarboxylic acid cycle and oxidative phosphorylation enzymes was significantly depressed in PGC-1alpha(-/-) mice and was activated by PGC-1alpha overexpression in the livers of WT mice. Collectively, these findings suggest that chronic whole-animal PGC-1alpha deficiency results in defects in hepatic glucose production that are secondary to diminished fatty acid beta-oxidation and tricarboxylic acid cycle flux rather than abnormalities in gluconeogenic enzyme gene expression per se.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670093      PMCID: PMC3047410          DOI: 10.1074/jbc.M600050200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Mechanisms by which liver-specific PEPCK knockout mice preserve euglycemia during starvation.

Authors:  Pengxiang She; Shawn C Burgess; Masakazu Shiota; Paul Flakoll; E Patrick Donahue; Craig R Malloy; A Dean Sherry; Mark A Magnuson
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

2.  Analysis of gluconeogenic pathways in vivo by distribution of 2H in plasma glucose: comparison of nuclear magnetic resonance and mass spectrometry.

Authors:  Shawn C Burgess; Merrill Nuss; Visvanathan Chandramouli; Dana S Hardin; Mark Rice; Bernard R Landau; Craig R Malloy; A Dean Sherry
Journal:  Anal Biochem       Date:  2003-07-15       Impact factor: 3.365

Review 3.  Metabolic control through the PGC-1 family of transcription coactivators.

Authors:  Jiandie Lin; Christoph Handschin; Bruce M Spiegelman
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

4.  PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice.

Authors:  K Tordjman; C Bernal-Mizrachi; L Zemany; S Weng; C Feng; F Zhang; T C Leone; T Coleman; D P Kelly; C F Semenkovich
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

5.  A comparison of three methods of glycogen measurement in tissues.

Authors:  J V Passonneau; V R Lauderdale
Journal:  Anal Biochem       Date:  1974-08       Impact factor: 3.365

6.  Quantifying gluconeogenesis during fasting.

Authors:  V Chandramouli; K Ekberg; W C Schumann; S C Kalhan; J Wahren; B R Landau
Journal:  Am J Physiol       Date:  1997-12

7.  Hepatic de novo synthesis of glucose 6-phosphate is not affected in peroxisome proliferator-activated receptor alpha-deficient mice but is preferentially directed toward hepatic glycogen stores after a short term fast.

Authors:  Robert H J Bandsma; Theo H Van Dijk; Anke ter Harmsel At; Tineke Kok; Dirk-Jan Reijngoud; Bart Staels; Folkert Kuipers
Journal:  J Biol Chem       Date:  2003-12-19       Impact factor: 5.157

8.  Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency.

Authors:  Timothy R Koves; Ping Li; Jie An; Takayuki Akimoto; Dorothy Slentz; Olga Ilkayeva; G Lynis Dohm; Zhen Yan; Christopher B Newgard; Deborah M Muoio
Journal:  J Biol Chem       Date:  2005-08-03       Impact factor: 5.157

9.  Use of 2H2O for estimating rates of gluconeogenesis. Application to the fasted state.

Authors:  B R Landau; J Wahren; V Chandramouli; W C Schumann; K Ekberg; S C Kalhan
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

10.  The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver.

Authors:  D H Williamson; P Lund; H A Krebs
Journal:  Biochem J       Date:  1967-05       Impact factor: 3.857

View more
  63 in total

1.  Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling.

Authors:  Kyle S McCommis; Zhouji Chen; Xiaorong Fu; William G McDonald; Jerry R Colca; Rolf F Kletzien; Shawn C Burgess; Brian N Finck
Journal:  Cell Metab       Date:  2015-09-03       Impact factor: 27.287

2.  Liver-specific loss of lipin-1-mediated phosphatidic acid phosphatase activity does not mitigate intrahepatic TG accumulation in mice.

Authors:  George G Schweitzer; Zhouji Chen; Connie Gan; Kyle S McCommis; Nisreen Soufi; Roman Chrast; Mayurranjan S Mitra; Kui Yang; Richard W Gross; Brian N Finck
Journal:  J Lipid Res       Date:  2015-02-26       Impact factor: 5.922

3.  Liver histone H3 methylation and acetylation may associate with type 2 diabetes development.

Authors:  Peipei Tu; Xiaodan Li; Baicheng Ma; Huikun Duan; Yaofang Zhang; Ri Wu; Zaizhong Ni; Pingzhe Jiang; Haisong Wang; Miao Li; Jianhong Zhu; Minggang Li
Journal:  J Physiol Biochem       Date:  2015-02-10       Impact factor: 4.158

4.  Dietary fat is a lipid source in 2,3,7,8-tetrachlorodibenzo-ρ-dioxin (TCDD)-elicited hepatic steatosis in C57BL/6 mice.

Authors:  Michelle Manente Angrish; Bryan David Mets; Arthur Daniel Jones; Timothy Richard Zacharewski
Journal:  Toxicol Sci       Date:  2012-04-26       Impact factor: 4.849

5.  Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.

Authors:  Justin A Fletcher; Melissa A Linden; Ryan D Sheldon; Grace M Meers; E Matthew Morris; Anthony Butterfield; James W Perfield; R Scott Rector; John P Thyfault
Journal:  Exp Physiol       Date:  2018-01-16       Impact factor: 2.969

6.  The molecular and metabolic influence of long term agmatine consumption.

Authors:  Itzhak Nissim; Oksana Horyn; Yevgeny Daikhin; Pan Chen; Changhong Li; Suzanne L Wehrli; Ilana Nissim; Marc Yudkoff
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

Review 7.  Nutrient-dependent regulation of PGC-1alpha's acetylation state and metabolic function through the enzymatic activities of Sirt1/GCN5.

Authors:  John E Dominy; Yoonjin Lee; Zachary Gerhart-Hines; Pere Puigserver
Journal:  Biochim Biophys Acta       Date:  2009-12-11

8.  PGC-1alpha negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb(alpha) axis.

Authors:  Jennifer L Estall; Jorge L Ruas; Cheol Soo Choi; Dina Laznik; Michael Badman; Eleftheria Maratos-Flier; Gerald I Shulman; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

9.  Sequence variation between the mouse and human glucose-6-phosphatase catalytic subunit gene promoters results in differential activation by peroxisome proliferator activated receptor gamma coactivator-1alpha.

Authors:  M M Schilling; J K Oeser; J K Chandy; B P Flemming; S R Allen; R M O'Brien
Journal:  Diabetologia       Date:  2008-06-19       Impact factor: 10.122

Review 10.  Fibroblast growth factor 21: from pharmacology to physiology.

Authors:  Steven A Kliewer; David J Mangelsdorf
Journal:  Am J Clin Nutr       Date:  2009-11-11       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.